Investors / United States / Deerfield
Deerfield
Venture capital · New York City, NY, United States · North America
Deerfield Management Company is an investment firm launched in 1994 that invests across the healthcare ecosystem and manages more than $16 billion in assets as of December 2025. It also operates Deerfield Discovery and Development (3DC), a company-building R&D engine, and Deerfield Intelligence, which analyzes healthcare data to inform investment decisions.
Invests inHealthcare & Biotech
In its own wordshealthcaretherapeuticsmedical deviceshealthcare servicesdigital healthdiagnostics
Your fit with Deerfield
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsDeerfield lists 9 checked portfolio companies on its own site and is named in 11 funding rounds, 4 of them as lead. Its most frequent entry is Series B, 50% of the companies with a known first round. Its largest themes are Healthcare & Biotech (82%), Industrial & Manufacturing (9%) and AI & Machine Learning (9%). 100% of its companies are based in United States. It invests most often alongside Regeneron Ventures, Canaan and Droia Ventures.
Counts come from funding rounds that name Deerfield, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundDeerfield does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 10% |
| Series A | 30% |
| Series B | 50% |
| Growth | 10% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 6 | 2 |
| '26 | 5 | 2 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 19th | 9 companies |
| Recent activity | 89th | 6 rounds in 12 months |
| Early stage | 55th | 10% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 94th | 82% in its largest sector |
| Reach | 19th | 1 country |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Regeneron Ventures | 3 |
| Canaan | 2 |
| Droia Ventures | 2 |
| EcoR1 Capital | 2 |
| Santé Ventures | 2 |
| ARCH Venture Partners | 1 |
| Acumen America | 1 |
| Arboretum Ventures | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers889%
- No longer answers00%
- Points to another company111%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 82% | 15% |
| Industrial & Manufacturing | 9% | 7% |
| AI & Machine Learning | 9% | 18% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Regeneron Ventures
Compare Deerfield head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Deerfield| Date | Company | Stage |
|---|---|---|
| 30 Oct 2026 | Series A | |
| 12 Aug 2026 | Series B Led | |
| 13 Apr 2026 | Series B Led | |
| 3 Dec 2025 | Series A Led | |
| 6 Nov 2025 | Round | |
| 25 Sept 2025 | Series A | |
| 13 Aug 2025 | Series B Led | |
| 18 Jun 2025 | Series B |
Round details for Deerfield
Amounts, full round histories and every co-investor in Deerfield's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
9 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Actio Biosciences is involved in clinical trials for therapies, including for KCNT1-Related Epilepsy. | Healthcare & Biotech | Jun 2025Series B | Funding round | |
Healthcare & BiotechIndustrial & Manufacturing | May 2025Seed | Funding round | ||
| Axon Therapies develops and offers a treatment for heart failure using a minimally invasive procedure called SAVM. | Healthcare & Biotech | Sept 2025Series A | Funding round | |
| Boulevard Bio is a clinical-stage, precision immunology company built to change the course of B cell-driven autoimmune diseases with targeted multi-specific medicines | Healthcare & Biotech | Aug 2026Series B | Funding round | |
| Excelsior Sciences develops and manufactures small molecules using automated chemistry techniques. | Healthcare & BiotechAI & Machine Learning | Dec 2025Series A | Funding round | |
| myLaurel provides acute and transitional care to high-complexity patients in their homes | Healthcare & Biotech | Nov 2025Round | Funding round | |
| Neomorph develops molecular glue degraders to target and destroy disease-causing proteins. | Healthcare & Biotech | Apr 2026Series B | Funding round | |
| Reprieve Cardiovascular develops a personalized intelligent decongestion management solution for Acute Decompensated Heart Failure patients | Healthcare & Biotech | Aug 2025Series B | Funding round | |
| Setara Biosciences develops small-molecule precision medicines that target the underlying causes of disease | Healthcare & Biotech | Oct 2026Series A | Funding round |
About this data
site last read 8 Nov 2026- Site
- deerfield.com
- Last read
- 8 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 9 May 2025
- Companies checked
- 9
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Deerfield's profile as data
Pull Deerfield's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/deerfield.com
# also
GET /v1/firms/deerfield.com/portfolio
GET /v1/firms/deerfield.com/coinvestors
GET /v1/firms/deerfield.com/news